NCT01559922View on ClinicalTrials.gov

Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

PHASE3CompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

February 28, 2014

Conditions
Atrophic Acne Scar
Interventions
DRUG

Normal Saline

Administration of up to 2 study treatments administered 6 weeks apart

DEVICE

Artefill

Administration of up to 2 study treatments administered 6 weeks apart

Trial Locations (10)

20769

Call Suneva for Info, Glenn Dale

33137

Call Suneva for Info, Miami Beach

33716

Call Suneva for Info, St. Petersburg

77056

Call Suneva for Info, Houston

90036

Call Suneva for Info, Los Angeles

90210

Call Suneva for Info, Beverly Hills

90404

Call Suneva for Info, Santa Monica

92121

Call Suneva for Info, San Diego

99204

Call Suneva for Info, Spokane

02481

Call Suneva for Info, Wellesley

All Listed Sponsors
collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Suneva Medical, Inc.

INDUSTRY

NCT01559922 - Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction | Biotech Hunter | Biotech Hunter